The effect of combined treatment of bevacizumab and triamcinolone for diabetic macular edema refractory to previous intravitreal mono-injections

Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema

(2014) Ursula Schmidt-Erfurth et al.   OPHTHALMOLOGY

Intravitreal Ranibizumab (Lucentis) for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis of Randomized Clinical Control Trials

(2012) Haiyan Wang et al.   CURRENT EYE RESEARCH

Ranibizumab for Diabetic Macular Edema

(2012) Quan Dong Nguyen et al.   OPHTHALMOLOGY

The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review

(2012) J. A. Ford et al.   BMJ-British Medical Journal

Changes in Aqueous Concentrations of Various Cytokines After Intravitreal Triamcinolone Versus Bevacizumab for Diabetic Macular Edema

(2011) Hee Jin Sohn et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Comparison of Grid Laser, Intravitreal Triamcinolone, and Intravitreal Bevacizumab in the Treatment of Diffuse Diabetic Macular Edema

(2011) Güngör Sobaci et al.   OPHTHALMOLOGICA

The RESTORE Study

(2011) Paul Mitchell et al.   OPHTHALMOLOGY

Combination therapy in diabetic macular oedema and retinal vein occlusion - past and present

(2010) Michael J. Koss et al.   ACTA OPHTHALMOLOGICA

Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema

(2010) Taygan Yilmaz et al.   ACTA OPHTHALMOLOGICA

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

(2010) P. Massin et al.   DIABETES CARE

Meta-analysis and review on the effect of bevacizumab in diabetic macular edema

(2010) Sunali Goyal et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration

(2009) Jost B. Jonas et al.   ACTA OPHTHALMOLOGICA

Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation

(2009) Marco S. Folgosa et al.   ACTA OPHTHALMOLOGICA

Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up

(2009) J. Fernando Arevalo et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab

(2009) Kayako Matsuyama et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Triamcinolone Acetonide Concentration of Aqueous Humor after Decanted 20-mg Intravitreal Injection

(2009) Lingyun Cheng et al.   OPHTHALMOLOGY

Randomized Trial of Intravitreal Bevacizumab Alone or Combined with Triamcinolone versus Macular Photocoagulation in Diabetic Macular Edema

(2009) Masoud Soheilian et al.   OPHTHALMOLOGY

Intravitreal Combination of Triamcinolone Acetonide and Bevacizumab (Kenacort-Avastin) in Diffuse Diabetic Macular Edema

(2009) Miltiadis K. Tsilimbaris et al.   Seminars in Ophthalmology

Is There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?

(2008) Shlomit Schaal et al.   OPHTHALMOLOGY

INTRAVITREAL TRIAMCINOLONE FOR DIABETIC MACULAR EDEMA

(2008) DAVID HAUSER et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES